Notice of Intent to Publish a Funding Opportunity Announcement for Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional)
ID: 353686Type: Forecasted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $750K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353686
Timeline
  1. 1
    Forecast Posted Apr 15, 2024 12:00 AM
  2. 2
    Forecast Due Jul 17, 2024 12:00 AM
  3. 3
    Posted Apr 22, 2024 12:00 AM
  4. 4
    Due Not available
Description

The National Institutes of Health (NIH) plans to publish a funding opportunity announcement for Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional). These centers are intended to support both basic and clinical research on Cystic Fibrosis (CF). The CF Research and Translation Centers provide shared resources to develop and test new therapies for CF and foster collaborations among institutions with a strong research base in CF. The funding opportunity will be available in April 2024, with an expected application due date in July 2024. The estimated total program funding is $6,200,000, and it is anticipated that five awards will be granted. The CF Research and Translation Centers play a crucial role in advancing CF research and improving treatments for individuals with CF.

Point(s) of Contact
No information provided.
Files
No associated files provided.
Similar Opportunities
Notice of Intent to Publish a Notice of Funding Opportunity for Diabetes Research Centers (P30 Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health (NIH) plans to publish a Notice of Funding Opportunity (NOFO) for Diabetes Research Centers (P30 Clinical Trial Optional). This initiative aims to solicit applications for research on diabetes, its complications, and related endocrine and metabolic diseases. The NOFO is expected to be published in Spring 2024, with an application due date in Summer 2024. The estimated total program funding is $7,500,000. The NOFO will utilize the P30 activity code. This opportunity falls under the category of Health and is a discretionary grant. The eligible applicants are others, and there is no cost sharing or matching requirement. The estimated synopsis post date is March 1, 2024, and the estimated synopsis close date is June 18, 2024. The estimated award date and project start date are both April 1, 2025.
Notice of Intent to Publish a Notice of Funding Opportunity for the Re-Issue of PAR-21-293 - Clinical and Translational Science Award (UM1 Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health (NIH) plans to reissue a Notice of Funding Opportunity (NOFO) for the Clinical and Translational Science Award (CTSA) Program hubs. This program aims to establish a collaborative consortium focused on advancing clinical and translational science (CTS) to bring more treatments to patients more quickly. The NOFO is expected to be published in Summer 2024, with an application due date in January 2025. The funding instrument type for this opportunity is a Cooperative Agreement. The estimated award date is December 16, 2025, and the estimated project start date is also December 16, 2025.
Notice of Intent to Publish a Funding Opportunity Announcement for Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health (NIH) plans to publish a Notice of Funding Opportunity (NOFO) for Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRCs). These centers aim to promote collaborative research in the field of muscular dystrophy and provide valuable resources for the national muscular dystrophy research community. The centers also serve as training grounds for new researchers in this field. It is expected that the NOFO will be published in Spring 2024, with an application due date in Summer 2024. Only new and renewal applications will be eligible for this grant opportunity. The estimated total program funding is $4,800,000, with an award ceiling of $1,000,000. The NOFO will utilize the P50 activity code. Further details will be provided in the upcoming NOFO.
Centers for AIDS Research (P30 Clinical Trial Not Allowed)
Active
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Centers for AIDS Research (P30 Clinical Trial Not Allowed)". This grant aims to provide administrative and shared research support to enhance HIV/AIDS research. The Centers for AIDS Research (CFAR) program emphasizes interdisciplinary collaboration across all areas of HIV/AIDS research. CFARs offer core facilities, expertise, resources, and services that are not easily obtained through traditional funding mechanisms. The grant does not require cost sharing or matching. The eligible applicants include various institutions and organizations such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and Historically Black Colleges and Universities (HBCUs). Non-domestic (non-U.S.) entities and components are not eligible to apply. The grant has a close date of August 4, 2025, and an archive date of September 9, 2025. For more information and to apply, visit the following link: [Centers for AIDS Research Grant](http://grants.nih.gov/grants/guide/pa-files/PAR-23-116.html). For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health (NIH) is offering Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers through a Grant opportunity. These grants aim to support three types of Cancer Centers: Comprehensive Cancer Centers, Clinical Cancer Centers, and Basic Cancer Centers. The purpose of these centers is to conduct research in various areas such as basic laboratory, clinical, prevention, control, and population-based research. The goal is to develop more effective approaches to cancer prevention, diagnosis, and therapy. The funding opportunity does not require cost sharing or matching. The maximum award ceiling is $1,500,000. The eligibility criteria include various types of institutions and organizations, excluding non-domestic (non-U.S.) entities. The closing date for applications is January 7, 2025. For more information and to apply, visit the following link: [http://grants.nih.gov/grants/guide/pa-files/PAR-21-321.html](http://grants.nih.gov/grants/guide/pa-files/PAR-21-321.html). For any inquiries, contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.